Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

KRX/011000 stock hub

KRX/011000 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/011000is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

102.4B

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/011000

In the news

Latest news · KRX/011000

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.8P50 17.1P75 31.9

Trailing P/En/a

P25 12P50 23.1P75 39.5

ROE-82

P25 -17.1P50 0.7P75 8.5

ROIC-29.5

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/011000 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

186

Groups with data

Currency

KRW

Showing 186 of 186 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	41
Enterprise value	KRW 133.6B
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Biotechnology
Isin	KR7011000007
Last refreshed	2026-05-10
Market cap	KRW 102.4B
Price	KRW 1,129
Price currency	KRW
Rev Per Employee	562,068,089.51x
Sector	Healthcare
Sic	2836
Symbol	krx/011000
Website	https://www.genels.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-50.65%
EV Earnings	-2.58x
EV/FCF	-8.06x
EV/Sales	5.8x
FCF yield	-16.18%
P/B ratio	2.5x
P/S ratio	4.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-191.09%
EBITDA Margin	-112.13%
Gross margin	-66.03%
Gross Profit	KRW -15.2B
Net Income	KRW -51.9B
Net Income Growth Quarters	1%
Net Income Growth Years	2%
Pretax Margin	-225.38%
Profit Margin	-225%
Profit Per Employee	KRW -1.3B
ROA	-20.35
Roa5y	-14.76
ROCE	-67.33
ROE	-81.98
Roe5y	-42.88
ROIC	-29.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-17.21%
Cagr15y	-5.38%
Cagr1y	-46.52%
Cagr20y	-13.97%
Cagr3y	-42.82%
Cagr5y	-36.34%
EPS Growth Quarters	1
EPS Growth Years	2
Revenue Growth	-35.49x
Revenue Growth Q	-74.76x
Revenue Growth Years	0x
Revenue Growth3 Y	-22.08x
Revenue Growth5 Y	-11.1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.17
Assets	KRW 119.2B
Cash	KRW 1.7B
Current Assets	KRW 19.4B
Current Liabilities	KRW 53.8B
Debt	KRW 33B
Debt Equity	KRW 0.81
Debt FCF	KRW -1.99
Equity	KRW 40.9B
Interest Coverage	-8.57
Liabilities	KRW 78.3B
Long Term Assets	KRW 99.8B
Long Term Liabilities	KRW 24.5B
Net Cash	KRW -31.2B
Net Cash By Market Cap	KRW -30.5
Net Debt Equity	KRW 0.76
Tangible Book Value	KRW 40.7B
Tangible Book Value Per Share	KRW 494
WACC	8.33

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.36
Inventory Turnover	2.56
Net Working Capital	KRW -25.4B
Quick ratio	0.07
Working Capital	KRW -34.4B
Working Capital Turnover	KRW -0.96

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.77%
Dividend per share	KRW 0
Last Dividend	KRW 53.33

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-84.87%
1Y total return	-46.49%
200-day SMA	1,838.9
3Y total return	-81.31%
50-day SMA	986.6
50-day SMA vs 200-day SMA	50under200
5Y total return	-89.54%
All Time High	54,933.3
All Time High Change	-97.94%
All Time High Date	2006-02-01
All Time Low	90.23
All Time Low Change	1,151.19%
All Time Low Date	1997-12-12
ATR	137.3
Beta	0.51
Beta1y	0.07
Beta2y	-0.19
Ch YTD	-42.37
High	1,129
High52	4,270
High52 Date	2025-05-26
High52ch	-73.56%
Low	890
Low52	618
Low52 Date	2026-04-10
Low52ch	82.69%
Ma50ch	14.43%
Price vs 200-day SMA	-38.6%
RSI	57.74
RSI Monthly	35.65
RSI Weekly	38.69
Sharpe ratio	-0.35x
Sortino ratio	-0.52
Total Return	-3.77%
Tr YTD	-42.37
Tr15y	-56.37%
Tr1m	38.36%
Tr1w	34.89%
Tr3m	-43.52%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -44B
Operating margin	-191.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	74,173,679%
Net Borrowing	16,403,650,730
Shares Insiders	6.78%
Shares Institutions	3.97%
Shares Out	90,673,443
Shares Qo Q	-2.97%
Shares Yo Y	3.77%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -16.6B
Average Volume	7,560,605x
Bv Per Share	496.8
CAPEX	KRW -23.8M
Ch10y	-89.18
Ch15y	-73.23
Ch1m	38.36
Ch1w	34.89
Ch1y	-46.49
Ch20y	-97.65
Ch3m	-43.52
Ch3y	-81.31
Ch5y	-89.92
Ch6m	-45.06
Change	29.92%
Change From Open	26.85
Close	869
Days Gap	2.42
Depreciation Amortization	18,196,238,230
Dollar Volume	7,773,682,082
Earnings Date	2026-05-14
EBIT	KRW -44B
EBITDA	KRW -25.8B
EPS	KRW -629
F Score	1
FCF	KRW -16.6B
FCF EV Yield	-12.4x
FCF Per Share	KRW -183
Financing CF	17,450,560,950
Fiscal Year End	December
Founded	1,976
Income Tax	KRW -86.4M
Investing CF	-769,890,700
Is Primary Listing	1
Last Earnings Date	2025-11-13
Last Report Date	2025-12-31
Last Split Date	2021-12-03
Last Split Type	Forward
Ma150	1,670.1
Ma150ch	-32.4%
Ma20	922.7
Ma20ch	22.36%
Net CF	138,544,510
Next Earnings Date	2026-05-14
Open	890
Position In Range	100
Ppne	95,399,783,420
Price Date	2026-05-08
Ptbv Ratio	2.52
Relative Volume	0.91x
Revenue	23,044,791,670x
Tax By Revenue	-0.37x
Tr20y	-95.06%
Tr6m	-45.06%
Volume	6,885,458
Z Score	-3.63

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does KRX/011000 pay a dividend?

Capital-return profile for this ticker.

Performance

KRX/011000 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/011000?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.0%

Share of float held by funds and institutions

Insider ownership

+6.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+3.8%

Negative means the company is buying back shares.

Technical

KRX/011000 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.7

Neutral momentum band

Price vs 200-day MA

-38.6%

50/200-day relationship not available

Beta (5Y)

0.51

Less volatile than the market

Sharpe ratio

-0.35

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/011000

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/011000 stock rating?

krx/011000 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/011000 analysis?

The full report lives at /stocks/krx/011000/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/011000?

The latest report frames krx/011000 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/011000 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.